Tenet Healthcare Corporation

NYSE:THC Stock Report

Market Cap: US$9.4b

Tenet Healthcare Management

Management criteria checks 2/4

Tenet Healthcare's CEO is Saum Sutaria, appointed in Sep 2021, has a tenure of 2.58 years. total yearly compensation is $18.52M, comprised of 8.1% salary and 91.9% bonuses, including company stock and options. directly owns 0.37% of the company’s shares, worth $35.24M. The average tenure of the management team and the board of directors is 3.1 years and 5.9 years respectively.

Key information

Saum Sutaria

Chief executive officer

US$18.5m

Total compensation

CEO salary percentage8.1%
CEO tenure2.6yrs
CEO ownership0.4%
Management average tenure3.1yrs
Board average tenure5.9yrs

Recent management updates

Recent updates

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Mar 18
Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Tenet Healthcare: Shrinking To Grow

Feb 04

Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

Dec 18
Tenet Healthcare Corporation (NYSE:THC) Might Not Be As Mispriced As It Looks

We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Nov 15
We Think Tenet Healthcare (NYSE:THC) Is Taking Some Risk With Its Debt

Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt

Oct 13

Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Aug 02
Is Tenet Healthcare (NYSE:THC) Using Too Much Debt?

Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now

Jul 28

Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

Apr 13
Does This Valuation Of Tenet Healthcare Corporation (NYSE:THC) Imply Investors Are Overpaying?

USPI and Providence extend hands to aid ambulatory surgical services

Feb 09

Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Jan 31
Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden

Tenet Healthcare: Compressed Multiples Appear Justified

Jan 27

Tenet Health gains on on report David Einhorn's Greenlight has stake

Jan 17

An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 22% Undervalued

Jan 13
An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 22% Undervalued

Tenet Healthcare: Earnings Headwinds With Mixed Technicals

Nov 11

Tenet Healthcare Q3 2022 Earnings Preview

Oct 19

Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Oct 09
Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?

Tenet Healthcare: Mixed Debate, Rate Neutral On Valuation

Aug 25

Tenet Healthcare Q2 2022 Earnings Preview

Jul 20

Here's Why We Think Tenet Healthcare (NYSE:THC) Is Well Worth Watching

Jul 15
Here's Why We Think Tenet Healthcare (NYSE:THC) Is Well Worth Watching

CEO Compensation Analysis

How has Saum Sutaria's remuneration changed compared to Tenet Healthcare's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$19mUS$2m

US$611m

Sep 30 2023n/an/a

US$469m

Jun 30 2023n/an/a

US$499m

Mar 31 2023n/an/a

US$414m

Dec 31 2022US$11mUS$1m

US$410m

Sep 30 2022n/an/a

US$558m

Jun 30 2022n/an/a

US$875m

Mar 31 2022n/an/a

US$957m

Dec 31 2021US$21mUS$1m

US$915m

Sep 30 2021n/an/a

US$1b

Jun 30 2021n/an/a

US$434m

Mar 31 2021n/an/a

US$402m

Dec 31 2020US$9mUS$1m

US$399m

Sep 30 2020n/an/a

-US$18m

Jun 30 2020n/an/a

-US$48m

Mar 31 2020n/an/a

-US$112m

Dec 31 2019US$14mUS$962k

-US$226m

Compensation vs Market: Saum's total compensation ($USD18.52M) is above average for companies of similar size in the US market ($USD8.42M).

Compensation vs Earnings: Saum's compensation has increased by more than 20% in the past year.


CEO

Saum Sutaria (50 yo)

2.6yrs

Tenure

US$18,518,110

Compensation

Dr. Saumya Sutaria, M.D., also known as Saum, serves as Member of Advisory Board at Vida Health, Inc. Dr. Sutaria served as Chief Operating Officer at Tenet Healthcare Corp. since January 06, 2019 until S...


Leadership Team

NamePositionTenureCompensationOwnership
Saumya Sutaria
Chairman & CEO2.6yrsUS$18.52m0.37%
$ 35.2m
Paola Arbour
Executive VP & Chief Information Officer5.9yrsUS$2.47m0.030%
$ 2.8m
Thomas Arnst
EVP, Chief Administrative Officer3.1yrsUS$3.67m0.0082%
$ 772.4k
Lisa Foo
Executive Vice President of Commercial Operations2.1yrsUS$3.24m0.020%
$ 1.9m
Sun Park
Executive VP & CFOless than a yearno datano data
William McDowell
Vice President of Investor Relationsno datano datano data
Jana Durfee
Senior VP & Chief Compliance Officerno datano datano data
Michael Maloney
Executive Vice President of Corporate Development7.2yrsno datano data
Clint Hailey
Chief Managed Care Officer & Senior VP16.8yrsno datano data
Liz Johnson
Chief Applied Clinical Informatics Officerno datano datano data
Andrew Johnston
Chief Administrative Officer - USPI1.3yrsno datano data
Ernest Franklin
Senior Vice President & Chief Clinical Operations Officer5.3yrsno datano data

3.1yrs

Average Tenure

54yo

Average Age

Experienced Management: THC's management team is considered experienced (3.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Saumya Sutaria
Chairman & CEO3.4yrsUS$18.52m0.37%
$ 35.2m
James Bierman
Independent Director6.5yrsUS$333.54k0.038%
$ 3.6m
Stephen Rusckowski
Independent Directorless than a yearUS$238.93k0%
$ 0
Meghan FitzGerald
Independent Director5.9yrsUS$339.04k0.022%
$ 2.1m
Joseph Kerrey
Lead Independent Director23.1yrsUS$541.53k0.047%
$ 4.4m
Richard Mark
Independent Director6.4yrsUS$335.04k0.017%
$ 1.6m
Richard Fisher
Independent Director6.4yrsUS$351.04k0.0041%
$ 382.9k
Tammy Romo
Independent Director9.1yrsUS$356.04k0.049%
$ 4.6m
Christopher Lynch
Independent Director4.7yrsUS$331.04k0.011%
$ 1.1m
Mark Kopser
Executive Chairman of Aspen Healthcare no datano datano data
Cecil Haney
Independent Director3.3yrsUS$327.04k0.0017%
$ 159.9k
Nadja West
Independent Director4.5yrsUS$320.04k0.018%
$ 1.7m

5.9yrs

Average Tenure

66yo

Average Age

Experienced Board: THC's board of directors are considered experienced (5.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.